Skip to main content
. 2019 Jul 29;19:742. doi: 10.1186/s12885-019-5970-0

Table 2.

Detailed location of PET-positive inguinal LN at primary diagnosis of anal cancer

Pat. No LN No LN station Cranio-caudal distance in cm Vessels radial distance in cm
LN Diameter Saphenous junction (RTOG) Anal verge Lesser tuberosity (AGITG) Lesser trochanter (BNG) Fem. Saph. Skin
1 1 inferior 1.2 −1 + 2.1 + 2.4 + 3 1.2 0.6 0.8
2 inferior 1.4 -1 + 2.1 + 2.4 + 3 1.4 0.7 1.1
2 3 superomedial 1.7 0 + 0.9 + 1.5 + 2.4 2.1 0.9
4 superomedial 1.6 −3 −0.5 0 + 1.0 2.4 0.8 1.2
5 inferior 1.5 −4 −1.5 − 0.5 0 1.4 0.9 1.2
6 inferior 1.3 −3 −0.5 + 0.5 + 1.0 2.1 1.0 0.7
7 inferior 1.0 −1 + 1.0 + 1.5 +4.0 0.8 0.9 1.6
3 8 superomedial 1.0 −0.3 3.3 3.3 3.9 1.1 0.5 0.9
4 9 inferior 1.2 −5.5 −2.5 −2.5 −0,5 1.8 0.7 1.6
10 inferior 2.6 −3 0 0 + 2 2.4 1.0 2.1
11 inferior 1.0 -3 0 0 + 2 1.7 0.7 2.5
12 inferior 1.0 −2.5 + 1.0 + 0.5 + 2.5 0.8 0.6 2.9
13 profound 2.6 0 +4 + 3 +4.5 1.7 1.3 1.2
14 superolateral 2.1 + 1.5 + 5 +4 + 6 2.6 0.8
15 superolateral 0.8 +4.5 + 7 + 6.0 + 7.5 2.8 0.6
16 inferior 1.0 −2 + 3 + 1.5 +4.0 0.7 1.1 2.9
17 superomedial 2.3 −1.2 + 3.6 + 4.1 + 5.7 1.4 1.3 1.1
18 profound 0.6 + 3.3 + 6.3 + 7.2 + 8.9 0.4 3.9
19 profound 1.0 +4.5 + 7.5 + 7.8 + 9.3 0.8 4.5
20 profound 0.6 + 1.3 +4.3 +4.8 + 6.7 0.4 2.8
21 profound 1.0 + 2.9 + 5.4 + 5.4 + 7.3 0.6 3.0
22 profound 0.9 + 3.2 + 6.4 + 7.3 + 8.9 0.7 2.4
5 23 superomedial 0.9 −1.4 + 5.5 + 3.4 + 5.4 0.7 0.7 2.7
6 24 superomedial 1.1 + 1,4 + 7.5 + 5.1 + 6.6 0.7 0.7 0.9
7 25 superomedial 1.4 + 2.5 + 7.4 + 6.3 + 6.4 2.5 2.8
8 26 superomedial 1.3 −1.6 + 3,6 + 3,6 + 3,6 1.4 0.6 2.9
27 profound 1.9 −1.8 + 3.9 + 3.9 + 3.7 1.3 1.0 1.6
28 profound 2.1 0 +4.3 +4.5 +4.4 1.1 1.5 3.1
29 profound 1.2 0 + 5.2 + 5.2 + 5.3 1.9 1.5 2.4
30 superolateral 1.4 + 2.3 + 5.5 + 5.4 + 5.4 1.7 2.1
31 profound 1.0 + 2.0 + 5.3 + 5.3 + 5.4 0.6 5.5
9 32 superomedial 1.3 + 2.1 + 5.1 + 5.6 + 7.0 0.7 0.7
33 profound 1.6 + 1.6 + 5.6 + 5.0 + 6.4 0.9 0.9
10 34 inferior 1.4 −5.7 −2.6 −0.7 −0.2 2.8 0.8 1.3
35 inferior 1.3 −5.6 −2.6 −0.6 0 2.3 0.7 1.5
36 inferior 1.5 −2.8 −0.7 + 1.3 3.2 1.3 0.8 1.3
37 inferior 1.2 −2.8 −0.7 + 1.4 + 3.3 1.4 0.8 1.5
38 superomedial 0.9 −1.9 + 1.3 + 3.4 +4.3 1.7 0.4 1.3
39 superolateral 1.2 − 0.6 + 3.1 + 5.1 + 6 1.3 0.7
40 profound 1.0 + 1.5 + 3.9 + 5.8 + 6.9 0.7 0.8
41 profound 1.0 + 2.5 +4.9 + 6.8 + 7.9 0.6 1.5
42 inferior 0.8 −1.9 + 1.4 + 3.4 +4.3 0.7 0.4 1.0
43 profound 1.2 −1.6 + 2.1 +4.1 + 5.1 0.8 1.0 3.0
44 superomedial 1.0 + 1.5 + 3.9 + 5.9 + 7.0 1.5 1.4
45 superomedial 0.9 + 2.4 +4.9 + 6.9 + 7.8 1.4 1.1
46 profound 0.8 + 2.4 +4.9 + 6.9 + 7.9 1.5 0.8
47 profound 0.7 + 2.3 +4.8 + 6.8 + 7.8 1.3 0.3
48 superolateral 0.7 + 3.4 + 5.3 + 7.3 + 8.3 0.9 0.6
49 superolateral 0.8 + 3.9 5.9 + 7.8 + 8.9 1.1 0.6

LN = Lymph node, Pat. = Patient, No = number, cm = centimetre, Saph. = great saphenous vein, Fem. = femoral vessels. RTOG = Radiation Oncology Group, AGITG = Australasian Gastrointestinal Trials Group, BNG = British National Guidance. + = cranial distance, − = caudal distance. Red = LN mainly outside elective CTV.